Dan Ives, Global Head of Technology Research at Wedbush Securities, talks about how Deepseek has transformed China's role in ...

If bearishness takes over the market, expect CRM to be part of a deep sell-off that pushes the stock back to the ...

Dan Ives, Managing Director and Senior Equity Analyst at Wedbush Securities, shares his expert insights on the future of AI, ...

Dan Ives, Wedbush Securities global head of technology research, joins CNBC's 'Squawk on the Street' to break down ...

Wedbush Securites, a 70-year-old financial services firm based in Los Angeles, has filed with the Securities and Exchange ...

Some of the $500 billion that Apple pledged Monday to invest in the U.S. will go to the massive Taiwan Semiconductor ...

Detailed price information for Palantir Technologies Inc Cl A (PLTR-Q) from The Globe and Mail including charting and trades.

Analysts at Wedbush issued their FY2029 earnings per share estimates for Aerovate Therapeutics in a research report issued to clients and investors on Monday, February 24th. Wedbush analyst L. Chico ...

Generally, companies are spending 10%-15 of their budgets on AI, and NVDA should benefit from this trend, Wedbush believes.

Poor European sales, strengthening competition and the activities of its eccentric CEO are all pressure on the company's ...